BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC
All information is at 30 September 2012 and unaudited.
Performance at month end with net income reinvested
One Three Since One Three Five
month months 1 April 12 year years Years
Sterling:
Share price 0.7% 7.3% 5.6% 13.5% 25.2% -10.5%
Net asset value 0.4% 4.5% 3.0% 18.4% 27.2% -8.3%
FSTE All-Share Total Return 1.1% 4.7% 1.9% 17.2% 26.1% 8.7%
Sources: BlackRock and Datastream
BlackRock took over the investment management of the Company with effect from 1
April 2012.
At month end
Sterling:
Net asset value - capital only: 142.89p
Net asset value - cum income*: 145.40p
Share price: 137.50p
Total assets (including income): £41.3m
Discount to cum-income NAV: 5.4%
Gearing: 5.0%
Net yield: 3.7%
Ordinary shares in issue**: 28,379,268
*includes net revenue of 2.51 pence per share
** excludes 4,554,664 shares held in treasury
Benchmark
Sector Analysis Total assets(%)
Oil & Gas Producers 13.85
Banks 9.79
Mining 9.50
Pharmaceuticals & Biotechnology 9.35
Mobile Telecommunications 8.58
Media 7.03
Tobacco 6.19
Food Producers 4.88
Non Life Insurance 3.56
Life Insurance 3.35
Equity Investment Instruments 3.05
Support Services 2.68
General Retailers 2.54
Software & Computer Services 2.49
Aerospace & Defence 2.36
Electronic & Electrical Equipment 2.12
Financial Services 2.10
Electricity 2.00
Real Estate Investment & Services 1.79
Gas, Water & Multiutilities 1.70
Technology Hardware & Equipment 1.28
Non Equity Investment Instruments 0.75
Net Current Liabilities (0.94)
------
Total 100.00
------
Ten Largest Equity Investments(in alphabetical order)
Company % of Total assets
Antofagasta 4.06
Astrazeneca 3.13
BHP Billiton 3.45
British American Tobacco 3.46
GlaxoSmithKline 3.91
HSBC 7.21
Royal Dutch Shell B 8.08
Tullow Oil 4.16
UBM 3.94
Vodafone 8.58
Commenting on the markets, Nick McLeod-Clarke & Adam Avigdori, representing the
Investment Manager noted:
Markets
Equity markets rose in the third quarter in response to stimulus measures
provided by the Federal Reserve, European Central Bank and Bank of Japan. The
rally was strongest in European peripheral markets as policy makers, notably
Draghi, signalled an intention to do whatever is necessary to underpin the
eurozone. In a reversal of trends from the previous quarter, the market's rally
left behind the more defensive shares: tobacco, mobile telecoms and oil
producers were the biggest negative contributors. Financials, led by banks and
life assurance, rallied strongly towards the end of the quarter as eurozone
risks were perceived to have diminished.
Portfolio Performance
The portfolio delivered a positive return in September of 0.4%, slightly
underperforming its benchmark the FTSE All Share Index (total return), which
returned 1.1%. The market's rotation away from companies with defensive
earnings saw Vodafone shares move lower, in part due to concerns over whether
or not the company will receive a dividend from its holding of Verizon Wireless
in the US, which continues to deliver growth. Imperial Tobacco shares were also
lower, hit by Australia's highest court upholding tough new anti-tobacco
marketing laws that require plain packaging. Not owning Barclays detracted from
returns after its shares bounced on decent results and on improving market
sentiment towards banks. Pharma company Shire suffered a period of poor share
price performance after US regulators approved a generic version of one of its
hyperactivity drugs.
On the positive side, despite investor concerns over slowing global growth and
lower demand for commodities, the strongest contributor to performance was
copper miner Antofagasta, which recovered from weaker performance earlier in
the year after its shares rose when the copper price strengthened in September.
Carphone Warehouse, specialist retailer of mobile electronic devices, continued
to perform well after it reported first quarter results that were ahead of
expectations. Business information and exhibitions group UBM continued to
progress well after reporting a good set of interim numbers, with the
exhibitions and conferences business, which is mainly focused on emerging
markets and China in particular, delivering growth ahead of market
expectations. Jupiter Fund Management was additive to returns after its shares
responded to the improving market sentiment after the central bank actions.
Plumbing goods supplier Wolseley benefited from indications that the US housing
market is seeing signs of revival.
Outlook
The macro environment remains stable but depressed, and a wide range of
outcomes are still possible. The recent interventions by the ECB, Federal
Reserve and Japanese Central Bank have provided a great deal of liquidity,
which may have reduced downside risk in the short term but this needs to
translate into growth to be effective.
Overall, UK equity valuations still look attractive compared to those of most
other asset classes, with the prospect of high quality earnings and dividend
growth. We expect domestic consumption to remain under pressure and hence we
prefer to hold positions in companies with exposure to growth markets. The UK
equity market has considerable exposure to overseas earnings and provides many
good investment opportunities.
17 October 2012
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.